The Reported Course of NR4A2-Related Syndrome
At a Glance
NR4A2-related syndrome often begins with developmental and language difficulties. Involuntary twisting or Parkinson-like movement problems may appear later, but timing and severity vary widely; a normal brain MRI does not rule it out, and levodopa helps some people.
The symptoms of NR4A2-related syndrome—also known as IDLDP—often unfold in a reported pattern. While the journey is different for every child, researchers have identified a potential “biphasic” (two-phase) course where early developmental challenges are sometimes followed years later by changes in how a person moves [1][2]. It is important to know that this is a reported pattern, not a guaranteed timetable; not everyone develops every symptom, and ages of onset vary widely.
Phase 1: Early Childhood Development
In the first several years of life, the syndrome primarily affects how a child learns and communicates. For many families, this is the stage where the first “red flags” appear.
- Developmental Delay and Intellectual Disability: Approximately 93% of children with this syndrome in reported literature experience delays in reaching milestones like sitting, crawling, or walking [3]. Many will have some level of intellectual disability, ranging from mild to severe [1][3].
- Language Impairment: Speech is often the most significantly affected area, with 63% of children experiencing major delays in expressive language [3]. In some cases, children may remain non-verbal or have very limited speech [4].
- Behavior and Social Features: Some children may show features of autism spectrum disorder or ADHD [5][4]. These can include challenges with social interaction, repetitive behaviors, or difficulty maintaining focus.
Phase 2: Movement Changes (Dystonia and Parkinsonism)
As children grow into late adolescence or early adulthood, a second set of symptoms may emerge. These are related to the brain’s supply of dopamine and can significantly impact physical mobility [1]. While these often appear later, they have been reported in younger children as well [6].
The movement disorders seen in NR4A2-related syndrome typically fall into two categories:
- Dystonia: This involves involuntary muscle contractions that force the body into twisting or repetitive movements and unusual postures [1].
- Parkinsonism: This is a group of symptoms that look like Parkinson’s disease but are caused by the genetic mutation rather than old age. Key signs include:
- Bradykinesia (slowness of movement).
- Hypokinesia (decreased range of motion, such as smaller steps or reduced arm swing).
- Rigidity (stiffness in the limbs or trunk) [1].
Movement symptoms in some patients have been dopa-responsive, meaning they improve with Levodopa treatment, though this response is variable [6].
Other Potential Symptoms
Beyond the major developmental and movement phases, several other symptoms are frequently reported:
- Seizures: About 41% of patients experience recurrent seizures or epilepsy [3]. These can vary widely in type and severity and may occur with or without the movement symptoms [5].
- Physical Features: Roughly 47% of individuals have other minor physical differences, such as unique facial features (25%), musculoskeletal issues like scoliosis (28%), or gastrointestinal problems (19%) [3].
- Normal Imaging: It is important to know that conventional brain MRI scans in patients with this syndrome are often reported as normal or nonspecific [1]. A normal MRI does not rule out the condition, nor does it prove that there is microscopic damage to dopamine cells; it simply shows that the gross structure of the brain appears typical.
The Challenge of Variability
It is critical to remember that this condition is highly variable. In one documented case, two individuals with the same type of mutation had only mild intellectual disability in childhood before developing movement issues in their 20s [1]. In other cases, movement issues and developmental delays are noticed much earlier [6]. Your child’s care team will need to monitor them closely through every transition from childhood to adulthood, utilizing a symptom timeline to track changes without assuming progression is inevitable.
Common questions in this guide
What signs may appear early in NR4A2-related syndrome?
When can dystonia or parkinsonism start in NR4A2-related syndrome?
Can a normal brain MRI rule out NR4A2-related syndrome?
Can levodopa improve movement problems caused by NR4A2-related syndrome?
What spells might suggest seizures in a child with NR4A2-related syndrome?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Developmental progress
Which developmental milestones, like sitting or walking, should we keep an eye on?
Movement symptoms
Could you explain the signs of dystonia and parkinsonism?
Treatment options
Could Levodopa be an option to discuss if movement symptoms develop?
Get notified when new evidence is published on Developmental delay-language impairment-dopa responsive dystonia-parkinsonism syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (6)
- 1
Loss-of-Function Mutations in NR4A2 Cause Dopa-Responsive Dystonia Parkinsonism.
Wirth T, Mariani LL, Bergant G, et al.
Movement disorders : official journal of the Movement Disorder Society 2020; (35(5)):880-885 doi:10.1002/mds.27982.
PMID: 31922365 - 2
Parkinsonism in children: Clinical classification and etiological spectrum.
Leuzzi V, Nardecchia F, Pons R, Galosi S
Parkinsonism & related disorders 2021; (82()):150-157 doi:10.1016/j.parkreldis.2020.10.002.
PMID: 33109474 - 3
Expanding the Clinical Spectrum of NR4A2-Related Disorder: A Systematic Literature Review and Case Series.
Borden C, Nasir MB, Roberts MB, et al.
American journal of medical genetics. Part A 2025; (197(10)):e64145 doi:10.1002/ajmg.a.64145.
PMID: 40497586 - 4
NR4A2 haploinsufficiency is associated with intellectual disability and autism spectrum disorder.
Lévy J, Grotto S, Mignot C, et al.
Clinical genetics 2018; (94(2)):264-268 doi:10.1111/cge.13383.
PMID: 29770430 - 5
Two novel heterozygous truncating variants in NR4A2 identified in patients with neurodevelopmental disorder and brief literature review.
Song X, Xu W, Xiao M, et al.
Frontiers in neuroscience 2022; (16()):956429 doi:10.3389/fnins.2022.956429.
PMID: 35992907 - 6
Combined molecular characterization and dopa-responsive treatment in two patients with NR4A2-associated intellectual developmental disorder.
Liang N, Li T, Deng Y
Frontiers in genetics 2025; (16()):1590292 doi:10.3389/fgene.2025.1590292.
PMID: 41019763
This page describes reported patterns in NR4A2-related syndrome for informational purposes only and does not constitute medical advice. Your child’s healthcare team can interpret symptoms, testing, and possible treatment response.